|
May 28
|
GSK CEO Says Drugmaker Can Navigate Potential New U.S. Tariffs
|
|
May 28
|
From Autos to Pharma, CEOs Navigate Tariff Impacts
|
|
May 28
|
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
|
|
May 24
|
GSK plc (GSK) Stock Rises as FDA Approves Nucala for COPD, CHMP Backs Blenrep for Cancer Treatment
|
|
May 23
|
GSK (LSE:GSK) Secures FDA Approval For COPD Treatment, Eyes European Nod For Blenrep
|
|
May 23
|
GSK plc (GSK)’s Asthma Drug Gets FDA Nod to Treat ‘Smoker’s Lung’
|
|
May 22
|
Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)
|
|
May 21
|
ATS 2025: GSK strengthens argument for twice-annual depemokimab
|
|
May 19
|
Why These 4 Women-Run Companies Deserve a Spot in Your Portfolio?
|
|
May 19
|
GSK’s Blood-Cancer Treatment Combinations Approved in Japan
|
|
Mar 12
|
The most popular stocks for investors in February
|
|
Mar 11
|
Bear Of The Day: TopBuild (BLD)
|
|
Mar 3
|
Is GSK plc (GSK) the Best Weight Loss Drug Stock to Buy According to Analysts?
|
|
Mar 3
|
GSK Full Year 2024 Earnings: EPS Misses Expectations
|
|
Mar 1
|
Is GSK plc (GSK) The Best Immunology Stock To Buy Now?
|
|
Feb 26
|
Why GSK plc (GSK) Is One of the Best Vaccine Stocks to Buy According to Hedge Funds
|
|
Feb 26
|
The ‘dreadful’ decline of a British drug giant – and why RFK Jr could make it worse
|
|
Feb 23
|
GSK plc (GSK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
|
|
Feb 21
|
GSK’s Sluggish Shares Seen at Risk of New Activist Campaign
|
|
Feb 19
|
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week (UPDATED)
|